MS

Trending/MS

3-D image of spinal cord in neck

Study shows drug reduces risk of relapse with neuromyelitis optica

ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder…

Sign up